BIM
RKDA icon

BlackRock Investment Management’s Arcadia Biosciences RKDA Stock Holding History

BlackRock Investment Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Hold
3
– – ﹤0.01% 3883
2016
Q3 		$4K Hold
3
– – ﹤0.01% 3815
2016
Q2 		$6K Sell
3
-31
-91% -$51.9K ﹤0.01% 3813
2016
Q1 		$77K Hold
34
– – ﹤0.01% 3246
2015
Q4 		$84K Hold
34
– – ﹤0.01% 3287
2015
Q3 		$84K Hold
34
– – ﹤0.01% 3312
2015
Q2 		$174K Buy
+34
New +$212K ﹤0.01% 3285

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock Investment Management's RKDA Position: Q4 2016 in Review

BlackRock Investment Management held its Arcadia Biosciences (RKDA) position steady in Q4 2016 at 3 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

BlackRock Investment Management first reported a position in RKDA in Q2 2015 and has held it in 7 quarters since. The position peaked at $174K in Q2 2015. 12 funds tracked by Wall St. Rank hold RKDA as of Q4 2016.

  • BlackRock Investment Management held 3 shares of Arcadia Biosciences worth $2K as of Q4 2016.
  • BlackRock Investment Management left its Arcadia Biosciences share count unchanged in Q4 2016.
  • Arcadia Biosciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3883 holding.
  • BlackRock Investment Management first reported a position in Arcadia Biosciences in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's Arcadia Biosciences position peaked at $174K in Q2 2015.
  • 12 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.